Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
J Cell Mol Med ; 28(8): e18228, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38520209

RESUMO

Osteoarthritis is one of the common diseases that seriously affects the quality of life of middle-aged and elderly people worldwide. Geniposidic acid (GPA) is extracted from Eucommia ulmoides that exhibits various pharmacological effects. This study investigated the function of GPA on osteoarthritis (OA) in IL-1ß-stimulated mouse chondrocytes and mouse OA model. Mouse OA model was established by destabilization of the medial meniscus (DMM) and GPA was given intraperitoneal injection. The results demonstrated that GPA could alleviate DMM-induced OA in mice. In vitro, IL-1ß-induced PGE2, NO, MMP1 and MMP3 were suppressed by GPA. Furthermore, IL-1ß-induced ferroptosis was inhibited by GPA, as confirmed by the inhibition of MDA, iron, and ROS, as well as the upregulation of GSH, GPX4, and Ferritin. In addition, GPA was found to increase the expression of Nrf2 and HO-1. And the inhibition of GPA on IL-1ß-induced inflammation and ferroptosis were prevented by Nrf2 inhibitor. In conclusion, GPA alleviates OA progression through inhibiting inflammation and chondrocytes ferroptosis via Nrf2 signalling pathway.


Assuntos
Ferroptose , Glucosídeos Iridoides , Osteoartrite , Humanos , Pessoa de Meia-Idade , Camundongos , Animais , Idoso , Condrócitos/metabolismo , Fator 2 Relacionado a NF-E2/metabolismo , Qualidade de Vida , Inflamação/tratamento farmacológico , Inflamação/metabolismo , Osteoartrite/tratamento farmacológico , Osteoartrite/metabolismo , Interleucina-1beta/metabolismo , Modelos Animais de Doenças , NF-kappa B/metabolismo
2.
Rapid Commun Mass Spectrom ; 38(14): e9768, 2024 Jul 30.
Artigo em Inglês | MEDLINE | ID: mdl-38746975

RESUMO

RATIONALE: Advances in sulfur isotope measurement techniques have led to increased analytical precision. However, accurate measurement of 36S remains a challenge. This difficulty arises primarily from unresolved isobaric interferences of 36SF5 + at m/z = 131 u, 186WF4 2+ and 12C3F5 +, which lead to scale compression. Theoretically, unresolved interference with 2% relative intensity could cause 1‰ underestimation in a sample with real δ36S = +60‰. METHODS: Our study develops an interference-free four-sulfur isotope measurement method by using the high-resolution mass spectrometer Panorama. The mass resolving power of Panorama allows the distinction of 186WF4 2+ and 12C3F5 + from 36SF5 +. RESULTS: The 186WF4 2+ relative intensity was initially 9.4% that of 36SF5 + but reduced to 1.5% through tuning, while 12C3F5 + relative intensity dropped from 74% to 40% after flushing with air. Three IAEA standards were analyzed with both Panorama and MAT 253. We obtained Δ36SIAEA-S-2 = 1.238 ± 0.040‰ and Δ36SIAEA-S-3 = -0.882 ± 0.030‰, relative to IAEA-S-1, from Panorama, and Δ36SIAEA-S-2 = 0.18 ± 0.02‰ and Δ36SIAEA-S-3 = 0.11 ± 0.14‰ from MAT 253, while δ34S values from the two instruments are consistent. CONCLUSION: The measurement discrepancies on 36S between Panorama and MAT 253 highlight the impact of scale compression due to unresolved isobaric interferences. Resolving this problem is crucial for accurate 36S analysis. We recommend replacing the filament material with rhenium, tuning the filament voltage, and avoiding carbon in instruments to eliminate or mitigate interferences. We propose future systematic efforts to calibrate the δ33S, δ34S, and δ36S of IAEA-S-1, IAEA-S-2, and IAEA-S-3 and advise bracketing all three reference materials in the measurement sequences, to enable calibration.

3.
Chem Biol Interact ; 388: 110835, 2024 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-38122922

RESUMO

Osteoarthritis (OA) is a common joint degenerative disease, and chondrocyte injury is the main pathological and physiological change. Ruscogenin (Rus), a bioactive compound isolated from Radix Ophiopogon japonicus, exhibits various pharmacological effects. The aim of this research was to test the role and mechanism of Rus on OA both in vivo and in vitro. Destabilized medial meniscus (DMM)-induced OA model was established in vivo and IL-1ß-stimulated mouse chondrocytes was used to explore the role of Rus on OA in vitro. In vivo, Rus exhibited protective effects against DMM-induced OA model. Rus could inhibit MMP1 and MMP3 expression in OA mice. In vitro, IL-1ß-induced inflammation and degradation of extracellular matrix were inhibited by Rus, as confirmed by the inhibition of PGE2, NO, MMP1, and MMP3 by Rus. Also, IL-1ß-induced ferroptosis was suppressed by Rus, as confirmed by the inhibition of MDA, iron, and ROS, as well as the upregulation of GSH, GPX4, Ferritin, Nrf2, and SLC7A11 expression induced by Rus. Furthermore, the suppression of Rus on IL-1ß-induced inflammation, MMPs production, and ferroptosis were reversed when Nrf2 was knockdown. In conclusion, Rus attenuated OA progression through inhibiting chondrocyte ferroptosis via Nrf2/SLC7A11/GPX4 signaling pathway.


Assuntos
Ferroptose , Osteoartrite , Espirostanos , Animais , Camundongos , Cartilagem/efeitos dos fármacos , Cartilagem/metabolismo , Cartilagem/patologia , Condrócitos/efeitos dos fármacos , Ferroptose/efeitos dos fármacos , Inflamação/metabolismo , Interleucina-1beta/metabolismo , Metaloproteinase 1 da Matriz/metabolismo , Metaloproteinase 3 da Matriz/genética , Metaloproteinase 3 da Matriz/metabolismo , Fator 2 Relacionado a NF-E2/metabolismo , Osteoartrite/tratamento farmacológico , Osteoartrite/metabolismo , Transdução de Sinais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA